Massachusetts General Hospital ACTG CRS (101)

Boston, Massachusetts 02114

0 studies enrolling now · 16 studies all time

What they study most

HIV Infection, HIV Infections, HIV-1 Infection, Hepatitis C Infection

Studies at this site

• Early ART to Limit Infection and Establishment of Reservoir — Completed
• Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen — Completed
• Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection — Completed
• Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) — Completed
• FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir — Completed
• Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells — Completed
• Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression — Completed
• High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART — Completed
• Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults — Completed
• Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV — Stopped early
• Sevelamer for Reducing Endotoxemia and Immune Activation — Completed
• Rifaximin as a Modulator of Microbial Translocation and Immune Activation — Completed
• Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients — Completed
• Modulation of Immune Activation by Aspirin — Completed
• Chloroquine for Reducing Immune Activation in HIV- Infected Individuals — Completed
• Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults — Completed